Companies

Nuvectis Pharma, Inc. (NVCT) SEC filings

CIK 0001875558 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Net income (USD)-26.4 M-22.3 M-19.1 M
Diluted EPS (USD/shares)-1.32-1.43-1.51

Latest filings

FiledFormDescriptionPeriod
2026-08-28EFFECTEFFECT items ,,
2026-08-21S-3FORM S-3
2026-08-218-KFORM 8-K items 8.01,9.012026-07-20
2026-08-06SCHEDULE 13GSCHEDULE 13G
2026-08-054OWNERSHIP DOCUMENT2026-08-03
2026-08-0410-Q10-Q2026-06-30
2026-08-048-KFORM 8-K items 2.02,9.012026-08-04
2026-07-014OWNERSHIP DOCUMENT2026-06-30
2026-07-014OWNERSHIP DOCUMENT2026-06-30
2026-06-308-KFORM 8-K items 1.01,8.01,9.012026-06-29
2026-06-30424B5424B5
2026-06-29424B5424B5
2026-06-298-KFORM 8-K items 8.012026-06-29
2026-06-238-KFORM 8-K items 1.01,8.01,9.012026-06-22
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-128-KFORM 8-K items 5.072026-06-11
2026-05-0510-Q10-Q2026-03-31
2026-05-058-KFORM 8-K items 2.02,9.012026-05-05
2026-04-27DEFA14ADEFA14A
2026-04-27DEF 14ADEF 14A2026-06-11
2026-02-20EFFECTEFFECT items ,,
2026-02-18CORRESPCORRESP

Forms on file (last 1,000): 4 128, 8-K 37, 10-Q 14, CORRESP 11, 3 9, SC 13G/A 7, UPLOAD 6, S-1/A 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NVCT (0.002 USD), /gw/filings/filings?ticker=NVCT&form=8-K, /gw/filings/facts?ticker=NVCT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange